HRTX insider trading — Heron Therapeutics, Inc.
No open-market insider purchases or sales were filed for Heron Therapeutics, Inc. (HRTX) in the last 90 days. Other insider transactions — such as stock awards, option exercises or tax withholding — are listed below.
Updated Oct 16, 2026.
Recent HRTX insider transactions
Every Form 4 filed by Heron Therapeutics, Inc. officers, directors and 10% owners in the last 90 days, newest first. P = open-market purchase, S = open-market sale; other codes are awards, option exercises, tax withholding or gifts.
| Trade date | Insider | Role | Type | Ownership | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|---|
| Aug 6, 2026 | Hensley Mark Earl | Chief Operating Officer | M · Option exercise | Direct | 31,250 | — | — | Form 4 |
| Aug 6, 2026 | Hensley Mark Earl | Chief Operating Officer | F · Tax withholding | Direct | 8,888 | $0.50 | $4K | Form 4 |
| Jul 31, 2026 | Hensley Mark Earl | Chief Operating Officer | M · Option exercise | Direct | 11,769 | — | — | Form 4 |
| Jul 31, 2026 | Forbes William P | EVP, Chief Development Officer | M · Option exercise | Direct | 11,694 | — | — | Form 4 |
| Jul 31, 2026 | Forbes William P | EVP, Chief Development Officer | F · Tax withholding | Direct | 3,326 | $0.50 | $2K | Form 4 |
| Jul 30, 2026 | Forbes William P | EVP, Chief Development Officer | M · Option exercise | Direct | 11,769 | — | — | Form 4 |
| Jul 30, 2026 | Forbes William P | EVP, Chief Development Officer | F · Tax withholding | Direct | 3,348 | $0.50 | $2K | Form 4 |
| Jul 31, 2026 | Duarte Ira | EVP, Chief Financial Officer | M · Option exercise | Direct | 11,694 | — | — | Form 4 |
| Jul 31, 2026 | Duarte Ira | EVP, Chief Financial Officer | F · Tax withholding | Direct | 3,326 | $0.50 | $2K | Form 4 |
| Jul 30, 2026 | Duarte Ira | EVP, Chief Financial Officer | M · Option exercise | Direct | 13,535 | — | — | Form 4 |
| Jul 30, 2026 | Duarte Ira | EVP, Chief Financial Officer | F · Tax withholding | Direct | 3,850 | $0.50 | $2K | Form 4 |
| Jul 31, 2026 | Collard Craig A | Chief Executive Officer | M · Option exercise | Direct | 34,789 | — | — | Form 4 |
| Jul 30, 2026 | Collard Craig A | Chief Executive Officer | M · Option exercise | Direct | 50,021 | — | — | Form 4 |
| Jul 19, 2026 | Collard Craig A | Chief Executive Officer | M · Option exercise | Direct | 13,797 | — | — | Form 4 |
| Jul 19, 2026 | Forbes William P | EVP, Chief Development Officer | M · Option exercise | Direct | 3,874 | — | — | Form 4 |
| Jul 19, 2026 | Forbes William P | EVP, Chief Development Officer | F · Tax withholding | Direct | 1,101 | $0.47 | $517 | Form 4 |
| Jul 19, 2026 | Duarte Ira | EVP, Chief Financial Officer | M · Option exercise | Direct | 3,874 | — | — | Form 4 |
| Jul 19, 2026 | Duarte Ira | EVP, Chief Financial Officer | F · Tax withholding | Direct | 1,101 | $0.47 | $517 | Form 4 |
HRTX insider trading FAQ
Are insiders buying HRTX stock?
Not on the open market. In the last 90 days, Heron Therapeutics, Inc. insiders made no open-market purchases, and no open-market sales. Purchases with the insider's own money are generally seen as a stronger signal than sales, which happen for many reasons (taxes, diversification, planned 10b5-1 sales).
Who are the insiders trading HRTX?
No insider bought or sold on the open market in the last 90 days.
Where does HRTX insider trading data come from?
Every transaction comes from SEC Form 4 filings on EDGAR. Company officers, directors and 10% owners must file a Form 4 within two business days of buying or selling. InsiderBolt reads these filings directly from the SEC.
More stocks with insider activity
Insider trading data is for informational purposes only and is not investment advice. Filings can be amended; always confirm details on SEC EDGAR.